Generate Biomedicines has moved back into focus after a sharp weekly gain, which puts fresh attention on whether the current share price lines up with the value carried on its balance sheet. With book value now in the sp
Why Is GENB (GENB) Stock Down Today?
Updated Nov 16, 2026 8:30 PM ET · Prev Close $12.07
Primary Move Catalyst & Conviction
50% Signal ConvictionGENB showing strong bearish momentum
GENB is down 10.8% today on 0.9x average volume. The move appears to be driven by general market sentiment and momentum traders.
Market & Sector Relative Strength
GENB lagging the S&P 500 by -11.28%Options Flow & Execution Desk
Recent GENB Catalyst Headlines
Verified WireAP Generate Biomedicines Inc. GENB on Thursday reported a loss of 87.
Gb-0895 is being evaluated in two Phase 3 severe asthma studies for dosing twice a year A single dose of Gb-0895 produced sustained pharmacological activity for at least six months in COPD Zealand Pharma collaboration pr
Anthropic outlined collaborations with six organizations, including Bristol Myers Squibb, Generate Biomedicines and BigHat Biosciences.
1–3 Day Expected Range & Key Level
35% Follow-ThroughWatch for breakdown below $10.77
Technical Regime (GENB)
BEARISH MA TREND1-Year Historical Move Analogs
39 EventsSessions in the past year where GENB moved >3.0% down:
Retail & Crowd Sentiment
BullishAbout GENB
Get Instant GENB Catalyst Alerts
Receive an email alert when GENB triggers an unusual volume breakout, options sweep, or rating shift.
Other Liquid Stocks Moving Today
All Today's MoversGENB Session & Catalyst FAQ
Why is GENB stock down today?
GENB is down 10.8% today on 0.9x average volume. The move appears to be driven by general market sentiment and momentum traders.
Is GENB stock a buy or sell right now?
Today's session carries a 50% catalyst conviction score on 0.88x relative volume (low participation). Our multi-factor model currently rates GENB as AVOID NEW MONEY. Review full valuation, quality, and timing signals on the GENB Buy or Sell Decision Brief →
What is GENB's intrinsic value and expected trading range?
At $10.47, GENB's modeled 1-to-3 session range is $10.44 – $10.98, with a key inflection level at $10.23 (support). Compare current price against multi-year cash flow projections in the GENB Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
What do RSI and moving averages signal for GENB?
RSI at 36.3 reflects soft below-midline momentum. GENB trades at $10.47 relative to its 20-day SMA ($13.30) and 50-day SMA ($14.24), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.